TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,982,000 | -34.0% | 701,690 | +47.7% | 0.02% | -17.4% |
| Q1 2022 | $4,519,000 | -48.4% | 475,190 | +5.0% | 0.02% | -39.5% |
| Q4 2021 | $8,753,000 | -42.6% | 452,353 | -1.3% | 0.04% | -44.9% |
| Q3 2021 | $15,247,000 | -53.2% | 458,146 | -45.4% | 0.07% | -50.7% |
| Q2 2021 | $32,554,000 | -20.0% | 839,254 | +0.9% | 0.14% | -22.2% |
| Q1 2021 | $40,712,000 | -42.3% | 831,547 | -38.7% | 0.18% | -54.8% |
| Q4 2020 | $70,532,000 | +82.3% | 1,355,852 | -8.3% | 0.40% | +100.0% |
| Q3 2020 | $38,698,000 | +44.1% | 1,478,729 | +2.3% | 0.20% | +30.1% |
| Q2 2020 | $26,849,000 | – | 1,445,052 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |